Correlation Between Dynavax Technologies and Intracellular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Intracellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Intracellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Intracellular Th, you can compare the effects of market volatilities on Dynavax Technologies and Intracellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Intracellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Intracellular.

Diversification Opportunities for Dynavax Technologies and Intracellular

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Dynavax and Intracellular is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Intracellular Th in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intracellular Th and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Intracellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intracellular Th has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Intracellular go up and down completely randomly.

Pair Corralation between Dynavax Technologies and Intracellular

Given the investment horizon of 90 days Dynavax Technologies is expected to generate 5.2 times less return on investment than Intracellular. But when comparing it to its historical volatility, Dynavax Technologies is 1.2 times less risky than Intracellular. It trades about 0.01 of its potential returns per unit of risk. Intracellular Th is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  5,425  in Intracellular Th on August 24, 2024 and sell it today you would earn a total of  3,144  from holding Intracellular Th or generate 57.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Dynavax Technologies  vs.  Intracellular Th

 Performance 
       Timeline  
Dynavax Technologies 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Intracellular Th 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Intracellular Th are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Intracellular demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Dynavax Technologies and Intracellular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dynavax Technologies and Intracellular

The main advantage of trading using opposite Dynavax Technologies and Intracellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Intracellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will offset losses from the drop in Intracellular's long position.
The idea behind Dynavax Technologies and Intracellular Th pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges